Nathan Ihle

Nathan Ihle

Company: Bolt Biotherapeutics

Job title: Vice President - Chemistry, Manufacturing, Controls & Quality

Seminars:

Live Discussion & Question Time 2:30 pm

Read more

day: Track C - Day 2 PM

Considerations for Bolt Biotherapeutics’ Non- Cytotoxic ADCs 2:10 pm

Immune-Stimulating Antibody Conjugates (ISACs) seek to extend the utility of ADCs beyond current applications Discussing Bolt’s ISAC technology, and comparing it to cytotoxic ADC technologies Sharing examples of unique CMC challenges and opportunities for ISACsRead more

day: Track C - Day 2 PM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.